1257044-40-8 CAS NO.1257044-40-8
- FOB Price: USD: /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T
- Available Specifications:
99%(50-100)Kilogram
- Product Details
Keywords
- 1257044-40-8
- 1257044-40-8
- 1257044-40-8
Quick Details
- ProName: 1257044-40-8
- CasNo: 1257044-40-8
- Molecular Formula: C45H50ClN7O7S
- Appearance: yellow powder
- Application: anti-cancer
- DeliveryTime: in 7 days
- PackAge: 25KG/drum or as your requirement
- Port: Shanghai/Beijing/Jiangsu/Tianjin
- ProductionCapacity: 100 Metric Ton/Year
- Purity: 99%
- Storage: Room temperature
- Transportation: Room Temperature
- LimitNum: 1 Kilogram
- Related Substances: 0.1%
- Residue on Ignition: 0.5%
- Valid Period: three year
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Our Advantange of Emtritabine:
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Details
the information of Venetoclax CAS: 1257044-40-8:
Product name |
Venetoclax | |
CAS No. |
1257044-40-8 | |
Molecular Formula |
|
|
Molecular Weight |
868.44 | |
Quality Standard |
98% up, Medicine Grade |
|
Appearance |
yellow powder |
2. The COA of Venetoclax CAS: 1257044-40-8:
The use of Venetoclax CAS: 1257044-40-8:
Venetoclax (VENCLYXTO), is a drug used to treat cancer. It is primarily used to treat certain types of leukemia and lymphoma and works by inhibiting B-cell maturation antigen (BCMA). The use of Vitela is not limited to the treatment of hematological malignancies, but also includes other types of tumors. Specifically, Victela can be used to treat a variety of B-cell malignancies, such as multiple myeloma and lymphoma, etc.